0. DOCID:18071 SCORE: 0.00321402048025523
DOCNO: 1792785
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: methods
QUALIFIER: administration & dosage
QUALIFIER: radiotherapy
AUTHOR: V A Chernichenko VA
AUTHOR: V S Ivankova VS
AUTHOR: E A Demina EA
AUTHOR: L L Zlochevskaia LL
PUBTYPE: Journal Article
JOURNALTITLE: Vrachebnoe delo.
COUNTRY: USSR
TITLE: [The treatment of patients with cancer of the corpus uteri using the gamma emitter 137Cs]
PUBDATE: 19911201
A study is presented of 51 patients (age 52-77 years) suffering of uterine body cancer with marked extragenital pathology. It is shown that treatment of inoperable cancer of the uterine body using the SELECTRON apparatus for contact irradiation (cesium-137 source, 066-MEV photons). With this method exact dose control is possible. The preferred regime of dose fractionation in intracavitary radiation of endometrium cancer is a single dose of 1000 cGr weekly and a summary dose of 7000-8000 cGr.


1. DOCID:19904 SCORE: 0.00231965700924742
DOCNO: 1831733
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Food Preservation
DESCRIPTOR: Vegetables
QUALIFIER: analysis
QUALIFIER: etiology
AUTHOR: C Ji C
AUTHOR: M Li M
AFFILIATION: Institute of Oncology, Beijing.
PUBTYPE: Journal Article
JOURNALTITLE: Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae.
COUNTRY: CHINA
TITLE: [Studies of pickled vegetables and cause of esophageal cancer in Linxian. II. Determination of nitrosamines and their precursors]
PUBDATE: 19910601
Pickled vegetables are daily food consumed in the high-risk areas for esophageal cancer in China. We analyzed the nitrosamine content of Linxian pickles by GC/TEA and found that trace amounts of six nitrosamines (NDMA, NDEA, NMBA, NMAMBA, NDPA, NPYR) were present, with the highest concentrations being NDMA and NDEA (1.7 and 1.9 micrograms/kg wet weight respectively). The average level of nitrosamine precursors, such as nitrate (111.22 mg/L), nitrite (0.152 mg/L) and secondary amines (4.223 mg/L), in pickled vegetables were determined, and their pH values ranged from 3 to 5.


2. DOCID:18081 SCORE: 0.00212824017757673
DOCNO: 1933212
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: pathology
QUALIFIER: pathology
QUALIFIER: pathology
AUTHOR: J M Dixon JM
AFFILIATION: University Department of Surgery, Royal Infirmary of Edinburgh, UK.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: British medical bulletin.
COUNTRY: ENGLAND
TITLE: Cystic disease and fibroadenoma of the breast: natural history and relation to breast cancer risk.
PUBDATE: 19910401
Approximately 25% of all 'discrete' breast lesions are fibroadenomas or breast cysts and they more commonly cause a breast lump than breast cancer. Despite their frequency, their natural history and relationship to subsequent breast cancer have not been clearly defined, although it would appear that palpable breast cysts, but not fibroadenomas, are associated with some increased risk of breast cancer. The diagnosis of these two entities is now possible by fine needle aspiration and excision of these lesions is only indicated in certain circumstances.


3. DOCID:23616 SCORE: 0.00204735583186001
DOCNO: 8979633
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: prevention & control
AUTHOR: P B Desai PB
PUBTYPE: Journal Article
JOURNALTITLE: Indian journal of medical sciences.
COUNTRY: INDIA
TITLE: Cancer control in the Asia Pacific region--the next lap.
PUBDATE: 19960201
Cancer control in any part of the world has to be a multi-directional effort addressed in a holistic manner. The general impression that cancer control means only collation of epidemiological data and efforts at primary prevention needs to be redefined because preventive and educative oncology, though an important component of cancer control, can achieve long-term goals only after 20 years or more. Along with such long-term objectives, methodology needs to be developed which takes care of immediate and recent needs in early diagnosis, effective treatment, and appropriate basic research for the ultimate control and cure of cancer. A holistic approach to the cancer control effort will, therefore, need the combined skills of many different specialists.


4. DOCID:20479 SCORE: 0.00203218791357207
DOCNO: 9447659
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Betaretrovirus
QUALIFIER: virology
QUALIFIER: virology
AUTHOR: M Palmarini M
AUTHOR: H Fan H
AUTHOR: J M Sharp JM
AFFILIATION: Cancer Research Institute, University of California Irvine 92697, USA. massimo@darwin.bio.uci.edu
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Trends in microbiology.
COUNTRY: ENGLAND
TITLE: Sheep pulmonary adenomatosis: a unique model of retrovirus-associated lung cancer.
PUBDATE: 19971201
Sheep pulmonary adenomatosis (SPA) is a contagious bronchiolo-alveolar carcinoma of sheep associated with an exogenous type D/B retrovirus known as jaagsiekte sheep retrovirus (JSRV). SPA represents a unique model for lung cancer, and studies on its aetiopathogenesis can provide further insight into the mechanisms of epithelial neoplasms.


5. DOCID:18362 SCORE: 0.00195822204942985
DOCNO: 2287471
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Surgical Flaps
QUALIFIER: surgery
AUTHOR: F Danieli F
AUTHOR: U Sicari U
AUTHOR: G Pinto G
AUTHOR: E Bortolozzi E
AUTHOR: M de Bernardin M
AUTHOR: F Gatto F
AUTHOR: N Bragato N
AUTHOR: G F Corso GF
AFFILIATION: Divisione Chirurgica, ULSS n. 17 Presidio Ospedaliero di Noale Venezia.
PUBTYPE: Journal Article
JOURNALTITLE: Minerva chirurgica.
COUNTRY: ITALY
TITLE: [Indications for the use of latissimus dorsi myocutaneous flap in breast reconstruction. Personal experience]
PUBDATE: 19900901
The paper illustrates the results of the application of the latissimus dorsi myo-cutaneous flap in breast reconstruction following mastectomy due to cancer in five patients with three different indications. Following a critical evaluation of the indications and results of breast reconstruction using the rectus abdominis myocutaneous flap, the Authors conclude by confirming the validity of indications given and the positive characteristics of the myo-cutaneous flap used.


6. DOCID:23662 SCORE: 0.00190985781945514
DOCNO: 7622109
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: utilization
QUALIFIER: radiotherapy
AUTHOR: A P Polednak AP
AFFILIATION: Connecticut Tumor Registry, Connecticut Department of Public Health and Addiction Services, Hartford 06106, USA.
PUBTYPE: Journal Article
JOURNALTITLE: Gynecologic oncology.
COUNTRY: UNITED STATES
TITLE: Declining use of radiotherapy for invasive cervical cancer in Connecticut: 1983-1990.
PUBDATE: 19950801
Data on the use of radiotherapy (i.e., external irradiation and/or intracavitary radioactive implants) in the first course of treatment were examined for all 1286 invasive cervical cancer cases diagnosed between 1983 and 1990 among Connecticut residents. These data, from a population-based cancer registry, reflect actual treatment practices in the geographic area under study. Use of radiotherapy declined from 62% in 1983 to 43% in 1990 (trend test P < 0.001); for "local"-stage cancers, the decline was from 50% in 1983 to 27% in 1990 (P < 0.001). Surveys are needed on physicians' attitudes and decisions regarding alternative treatments for cervical cancer.


7. DOCID:23699 SCORE: 0.00190985524122149
DOCNO: 8618397
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: therapy
QUALIFIER: therapy
AUTHOR: P Kelty P
AUTHOR: H Frazier H
AUTHOR: K O'Connell K
AUTHOR: B C Ghosh BC
AFFILIATION: Department of Urology, National Naval Medical Center, Bethesda, Maryland 20889-5000, USA.
PUBTYPE: Journal Article
JOURNALTITLE: Journal of surgical oncology.
COUNTRY: UNITED STATES
TITLE: Germ cell testis cancer: 15-year review.
PUBDATE: 19960501
Testis cancer affects 2-3 men per every 100,000 in the United States, making it the most common solid tumor of men in the 20-35-year-old age range. Since the average age of active duty military personnel is included in the age range of those at greatest risk for germ cell testis cancer, it is of pertinent clinical importance to physicians who treat these young patients. The National Naval Medical Center has been using cisplatin-based protocols since the time of their introduction. This study reviews the success of treating these patients and examines the treatment failures.


8. DOCID:17352 SCORE: 0.00190899902804983
DOCNO: 1914752
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: surgery
QUALIFIER: methods
QUALIFIER: surgery
QUALIFIER: prevention & control
QUALIFIER: adverse effects
QUALIFIER: utilization
AUTHOR: D B Evans DB
AUTHOR: C R Shumate CR
AUTHOR: F C Ames FC
AUTHOR: T A Rich TA
AFFILIATION: Department of General Surgery, University of Texas M. D. Anderson Cancer Center, Houston 77030.
PUBTYPE: Case Reports
PUBTYPE: Journal Article
JOURNALTITLE: Diseases of the colon and rectum.
COUNTRY: UNITED STATES
TITLE: Use of Dexon Mesh for abdominal partitioning above the peritoneal reflection.
PUBDATE: 19910901
Dexon Mesh (Davis & Geck, Sugarland, TX) was used to partition the abdomen after incomplete resection of a locally advanced left colon cancer. Following surgery, external beam radiotherapy was delivered to the left flank without the risk of radiation enteritis. The technique of abdominal partitioning using Dexon Mesh is described.


9. DOCID:18261 SCORE: 0.00190819810537485
DOCNO: 1663942
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Neoplasm Staging
QUALIFIER: pathology
QUALIFIER: pathology
AUTHOR: P Murphy P
AUTHOR: D H Johnson DH
AFFILIATION: Division of Medical Oncology, Vanderbilt University School of Medicine, Nashville, Tennessee.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Hematology/oncology clinics of North America.
COUNTRY: ENGLAND
TITLE: Staging and prognostic factors in nonseminomatous testicular cancer.
PUBDATE: 19911201
Staging of nonseminomatous testicular cancers, as with other tumors, renders important prognostic information and is necessary for making appropriate treatment recommendations. There is no universally accepted staging system for testis cancer, however. Despite the lack of uniformity, most of the staging systems in use today are capable of segregating patients into a "good-risk" or "poor-risk" category. The former group experiences cure less frequently and are appropriate candidates for investigational treatment. Tumor bulk is the most important prognostic factor in virtually all staging systems.


10. DOCID:17478 SCORE: 0.00190183930834474
DOCNO: 1738741
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: etiology
QUALIFIER: radiation effects
QUALIFIER: adverse effects
AUTHOR: M A Arsenian MA
AFFILIATION: Cape Ann Medical Center, Gloucester, Massachusetts.
PUBTYPE: Journal Article
JOURNALTITLE: Postgraduate medicine.
COUNTRY: UNITED STATES
TITLE: Heart disease after mediastinal radiotherapy.
PUBDATE: 19920201
The greatest risk for most cancer patients is inadequate treatment of their disease. Although mediastinal radiotherapy is a safer procedure than it was 20 years ago, it still may damage the thoracic viscera, including the heart. Cardiovascular problems tend to present subtly years later, when the patient may not recall the prior radiation or may not deem it significant. An awareness of this long latency period and of the wide spectrum of heart disease that may result from radiotherapy is essential for management of these patients.


11. DOCID:20940 SCORE: 0.00189533045288505
DOCNO: 9270709
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: prevention & control
QUALIFIER: prevention & control
QUALIFIER: therapeutic use
AUTHOR: M Meydani M
AUTHOR: J G Meisler JG
AFFILIATION: Vascular Biology Program, United States Department of Agriculture, Tufts University, Boston, USA.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Postgraduate medicine.
COUNTRY: UNITED STATES
TITLE: A closer look at vitamin E. Can this antioxidant prevent chronic diseases?
PUBDATE: 19970801
Vitamin E, the most effective natural free radical scavenger identified to date, is taking America by storm-and apparently for good reason. Reports of benefits ranging from Improved Immunity to prevention of cancer and cardiovascular disease are appearing regularly. In this article, the authors review the scientific literature to help you evaluate whether patients might benefit from supplemental vitamin E.


12. DOCID:18503 SCORE: 0.00189463835630646
DOCNO: 1838830
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Postoperative Complications
QUALIFIER: etiology
AUTHOR: S R Rossetti SR
AUTHOR: D F Randone DF
AFFILIATION: Clinica Urologica, Università di Torino.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Archivio italiano di urologia, nefrologia, andrologia : organo ufficiale dell'Associazione per la ricerca in urologia = Urological, nephrological, and andrological sciences.
COUNTRY: ITALY
TITLE: [Surgical interventions and andrological complications]
PUBDATE: 19911201
Several abdomino-Pelvic surgical procedures can cause ejaculatory failure or impotence. Retroperitoneal lymph node dissection for testis cancer is followed by loss of ejaculation if bilateral. In low stage cancers, monolateral procedure is associated with maintenance of ejaculation in most patients. Evaluation of seminal fluid before surgery is essential for cryopreservation and artificial insemination erectile impotence is consequent to section of "nervi erigentes" in pelvic surgery for cancer. Careful anatomic dissection can spare these nerves but oncologic radicality should be always kept in mind.


13. DOCID:22567 SCORE: 0.00186400026455681
DOCNO: 7604194
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: epidemiology
AUTHOR: S S Devesa SS
AFFILIATION: Descriptive Studies Section, National Cancer Institute, Bethesda, MD 20892, USA.
PUBTYPE: Journal Article
JOURNALTITLE: Seminars in oncology nursing.
COUNTRY: UNITED STATES
TITLE: Cancer patterns among women in the United States.
PUBDATE: 19950501
The American Cancer Society estimated that 576,000 invasive cancers would be diagnosed among American women in 1994 and that 255,000 women will have died of cancer during that year. Six cancers account for almost 70% of the cases in women and more than 60% of the deaths. Risk factors associated with breast, lung, colorectal, cervix uteri, corpus uteri, and ovarian cancers are presented. The patterns of occurrence in the population, time trends, survival rates, and etiologic factors vary considerably, suggesting a constellation of diseases in women. One of the most important factors influencing outcome is early diagnosis.


14. DOCID:18334 SCORE: 0.0018624641382448
DOCNO: 1371563
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: therapeutic use
QUALIFIER: drug therapy
AUTHOR: T J Kennedy TJ
AUTHOR: A M Sonneland AM
AUTHOR: M M Marlett MM
AUTHOR: R H Troup RH
PUBTYPE: Journal Article
JOURNALTITLE: The Journal of urology.
COUNTRY: UNITED STATES
TITLE: Luteinizing hormone-releasing hormone downstaging of clinical stage C prostate cancer.
PUBDATE: 19920301
A total of 7 patients with clinical stage C prostate cancer determined by digital rectal examination, transrectal ultrasonography, radionuclide bone scanning and serum prostatic acid phosphatase determination was treated with luteinizing hormone-releasing hormone analogues for 2 to 5 months in an attempt to downstage the disease. Although substantial decreases in prostate specific antigen level and prostatic volume occurred, only 2 patients experienced pathological downstaging of disease. We conclude that luteinizing hormone-releasing hormone therapy for downstaging of clinical stage C prostatic cancer is of limited value.